News - Smith+Nephew
WEBsmith&[email protected] We design and manufacture technology that takes the limits off living. We support healthcare professionals to return their patients to health and mobility, helping them to perform at their fullest potential.
Smith+Nephew Fourth Quarter and Full Year 2023 Results
WEBFeb 27, 2024 · Fourth Quarter 2023 Trading Update. Our fourth quarter revenue was $1,458 million (2022: $1,365 million), up 6.4% on an underlying basis (reported revenue growth of 6.8% after 40bps foreign exchange tailwind). There were 60 trading days in the quarter, in-line with 2022.
Smith+Nephew acquires novel cartilage regeneration technology …
WEBNov 22, 2023 · Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces that it has entered into a definitive agreement to acquire CartiHeal, developer of Agili-C, a novel sports medicine technology for cartilage regeneration in the knee.
Smith+Nephew First Quarter 2024 Trading Update
WEBMay 1, 2024 · Smith+Nephew First Quarter 2024 Trading Update. Solid start to 2024, reinforcing confidence in full year outlook. Smith+Nephew (LSE:SN, NYSE:SNN) trading update for the first quarter ended 30 March 2024. Download a …
Smith+Nephew Second Quarter and First Half 2023 Results
WEBAug 3, 2023 · Delivering our transformational Strategy for Growth. Smith+Nephew delivered a strong trading performance in the first half of 2023, with revenue of $2,734 million (H1 2022: $2,600 million). This represented growth of 7.3% on an underlying basis, ahead of …
Smith+Nephew Fourth Quarter and Full Year 2022 Results
WEBFeb 21, 2023 · Smith+Nephew Fourth Quarter Trading and Full Year 2022 Results. Group revenue in 2022 was $5,215 million, an increase of 4.7% on an underlying basis (reported growth of 0.1% after 460bps headwind from foreign exchange primarily due to the strength of the US Dollar).
Smith+Nephew announces new UK R&D and manufacturing …
WEBJun 9, 2022 · Smith+Nephew will invest more than $100 million to create a world-class R&D, manufacturing and flexible office environment. The development will also be supported by a grant from UK Government. The new facility is expected to support more than $10 billion of sales in its first ten years of operation. Simon Fraser, President of Advanced Wound ...
Smith+Nephew First Quarter 2023 Trading Update
WEBApr 26, 2023 · Smith+Nephew (LSE:SN, NYSE:SNN) trading update for the first quarter ended 1 April 2023. Highlights 1,2 Q1 revenue $1,356 million (2022: $1,306 million), up 6.9% on an underlying basis and up 3.8% on a reported basis (including -310bps foreign exchange impact)
Smith+Nephew Second Quarter and First Half 2024 Results
WEBAug 1, 2024 · Our first half revenue was $2,827 million (H1 2023: $2,734 million), up 4.3% on an underlying basis and up 3.4% on a reported basis, including a translational foreign exchange headwind of -90bps. The first half comprised 127 trading days, in line with the equivalent period in 2023.
Smith+Nephew completes acquisition of novel cartilage …
WEBJan 10, 2024 · Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces that it has completed the acquisition of CartiHeal, developer of Agili-C, a novel sports medicine technology for cartilage regeneration in the knee.